Cash-burning healthcare companies looking to go public may turn to alternative methods of funding to keep their businesses afloat amid a flagging market for initial share sales, industry analysts say.
The IPO market for healthcare tech companies is facing its worst year in two decades as the COVID-19 pandemic, Russia’s war in Ukraine, record-high inflation and rising interest rates have squeezed public market valuations and sent stocks plunging.
